In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Clinical Trials - Diseases by specialty group
Late Effects and Supportive Studies 5
-
Protocol ID
- Associated disease
- Title
-
IIT-NEWMAN-ECTP
- Late Effects and Supportive Studies
- Communication in the Early Pediatric Cancer Treatment Period
-
IIT-STEINECK-SARCAT-QOL
- Late Effects and Supportive Studies
- SARCAT-QOL: Patient Reported Quality of Life After Treatment for Pediatric High-Risk Bone and Soft Tissue Sarcomas
-
NYMC-579
- Late Effects and Supportive Studies
- A Pilot Study in the Treatment of Refractory Adenovirus (ADV) Infection with Related Donor ADV Cytotoxic T-Lymphocytes (ADV-CTLs) in Children, Adolescents and Young Adult Recipients
-
NYMC-580
- Late Effects and Supportive Studies
- A Pilot Study in the Treatment of Refractory Cytomegalovirus (CMV) Infections with Related Donor CMV Specific Cytotoxic T-Cells (CTLs) in Children, Adolescents and Young Adult Recipients
-
NYMC-581
- Late Effects and Supportive Studies
- A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection with Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
